Delivery Order 36F79721D0073-36C25924F0067

Award Date 12/15/23
Potential Completion Date 12/14/24
Potential Value $218K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Aurora, CO 80045, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This federal contract award is for the supply of BinaxNOW COVID-19 rapid antigen tests to the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 19. The contract was awarded to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for a ceiling value of $217,564.56. The contract is a delivery order under the GSA Schedule 65-VII for in vitro diagnostics, reagents, and tests, with a firm fixed-price pricing structure. No set-aside designation was used.

Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products to various government agencies, including the VA and Department of Defense. In addition to this contract, the company holds several indefinite delivery/indefinite quantity vehicles with the VA to provide medical diagnostic equipment and testing supplies, particularly to support the agency's ongoing COVID-19 testing needs across its healthcare network. The parent company, Abbott Laboratories Inc., is also a significant federal contractor, providing a range of medical devices, diagnostic equipment, and testing supplies to government customers.

Generated 2/7/25, 9:20 AM